Thirty Madison Overview
- Year Founded
-
2017

- Status
-
Private
- Employees
-
700

- Latest Deal Type
-
Later Stage VC
- Investors
-
41
Thirty Madison General Information
Description
Operator of a human-first healthcare company intended to support the unique needs of the community with personalized treatments and care. The company builds condition-specific brands that provide end-to-end care for hair loss, a cove for migraine, a picnic for allergies, a facet for skin conditions, enabling patients to get specialized healthcare brands that creats exceptional outcomes for all.
Contact Information
Website
www.thirtymadison.comCorporate Office
- 82 Nassau Street
- Suite 61392
- New York, NY 10038
- United States
Corporate Office
- 82 Nassau Street
- Suite 61392
- New York, NY 10038
- United States
Thirty Madison Timeline
Thirty Madison Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
9. Later Stage VC | 01-Feb-2024 | Completed | Generating Revenue | |||
8. Debt - General | 12-Jun-2023 | Completed | Generating Revenue | |||
7. Mezzanine | 30-Dec-2022 | Completed | Generating Revenue | |||
6. Later Stage VC (Series C) | 02-Jun-2021 | Completed | Generating Revenue | |||
5. Early Stage VC (Series B) | 06-Mar-2020 | Completed | Generating Revenue | |||
4. Debt - General | 01-Jan-2020 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 16-Oct-2018 | Completed | Generating Revenue | |||
2. Early Stage VC | 14-Nov-2017 | $5M | $7.75M | Completed | Startup | |
1. Seed Round | 19-May-2017 | $2.75M | $2.75M | Completed | Startup |
Thirty Madison Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B-3 | ||||||||
Series B-2 | ||||||||
Series B-1 | ||||||||
Series A | ||||||||
Seed 2 | 3,476,042 | $0.000010 | $0.11 | $1.37 | $1.37 | $1.37 | 6.43% | |
Seed 1 | 4,305,276 | $0.000010 | $0.05 | $0.64 | $0.64 | $0.64 | 7.97% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Thirty Madison Comparisons
Industry
Financing
Details
Thirty Madison Competitors (4)
One of Thirty Madison’s 4 competitors is Nurx, a Formerly VC-backed company based in San Francisco, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Nurx | Formerly VC-backed | San Francisco, CA | ||||
Omada | Venture Capital-Backed | San Francisco, CA | ||||
Ro | Venture Capital-Backed | New York, NY | ||||
Teladoc Health | Formerly VC-backed | New York, NY |
Thirty Madison Signals
Thirty Madison Investors (41)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
CVS Health Ventures | Corporate Venture Capital | Minority | ||
Tournon Ventures | Venture Capital | Minority | ||
137 Ventures | Venture Capital | Minority | ||
Alpha Partners | Venture Capital | Minority | ||
Atacama Ventures | Venture Capital | Minority |
Thirty Madison Investments & Acquisitions (2)
Thirty Madison’s most recent deal was a Corporate Asset Purchase with Hey Favor (Certain Pharmaceutical Assets) for . The deal was made on 13-Jun-2023.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Hey Favor (Certain Pharmaceutical Assets) | 13-Jun-2023 | Corporate Asset Purchase | Specialty Retail | ||
Nurx | 01-Feb-2022 | Merger/Acquisition | Other Healthcare Services |
Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Nurx | San Francisco, CA | 2014 |
Thirty Madison FAQs
-
When was Thirty Madison founded?
Thirty Madison was founded in 2017.
-
Where is Thirty Madison headquartered?
Thirty Madison is headquartered in New York, NY.
-
What is the size of Thirty Madison?
Thirty Madison has 700 total employees.
-
What industry is Thirty Madison in?
Thirty Madison’s primary industry is Clinics/Outpatient Services.
-
Is Thirty Madison a private or public company?
Thirty Madison is a Private company.
-
What is Thirty Madison’s current revenue?
The current revenue for Thirty Madison is
. -
How much funding has Thirty Madison raised over time?
Thirty Madison has raised $249M.
-
Who are Thirty Madison’s investors?
CVS Health Ventures, Tournon Ventures, 137 Ventures, Alpha Partners, and Atacama Ventures are 5 of 41 investors who have invested in Thirty Madison.
-
Who are Thirty Madison’s competitors?
Nurx, Omada, Ro, and Teladoc Health are competitors of Thirty Madison.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »